<p>Janet Hapgood of the University of Cape Town in South Africa will use ex vivo primary epithelial cell models and cervical tissue explants to investigate how different progestins currently used in contraceptives might affect susceptibility to and transmission of HIV-1.</p>


Janet Hapgood of the University of Cape Town in South Africa will use ex vivo primary epithelial cell models and cervical tissue explants to investigate how different progestins currently used in contraceptives might affect susceptibility to and transmission of HIV-1.